Drug Type Immune stimulating antibody conjugate (ISAC) |
Synonyms antibody-Resiquimod conjugate + [1] |
Target |
Mechanism CAIX inhibitors(Carbonic anhydrase IX inhibitors), TLR7 agonists(Toll like receptor 7 agonists), TLR8 agonists(Toll like receptor 8 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H29N5O4 |
InChIKeyVEGGTWZUZGZKHY-GJZGRUSLSA-N |
CAS Registry159857-79-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 06 Dec 2023 |